RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 2,500 | +376.2% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 525 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 525 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 525 | -32.3% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 775 | -0.1% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 776 | +21.2% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 640 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | -86.7% | 640 | -66.5% | 0.00% | – |
| Q1 2020 | $15,000 | – | 1,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |